Galecto, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AADI
|
Aadi Bioscience, Inc. | $2.21 | $42.72 M | -0.68 | 53 | $24.35 M |
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.39 | $157.41 M | -2.5 | 51 | $0 |
 ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $6.37 | $223.86 M | -2.51 | 58 | $0 |
 ALGS
|
Aligos Therapeutics, Inc. | $18.52 | $40.52 M | -0.51 | 68 | $15.53 M |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $5.23 | $120.37 M | -1.65 | 384 | $380.79 M |
 BOLT
|
Bolt Biotherapeutics, Inc. | $0.58 | $29.02 M | -0.46 | 100 | $7.88 M |
 CGEM
|
Cullinan Oncology, Inc. | $13.10 | $1.29 B | -7.16 | 85 | $0 |
 CHRS
|
Coherus BioSciences, Inc. | $0.83 | $193.89 M | -2.28 | 235 | $257.24 M |
 CNTA
|
Centessa Pharmaceuticals plc | $16.83 | $884.24 M | -6.2 | 76 | $6.85 M |
 CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.52 | $1.12 B | -5.11 | 174 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $31.49 | $1.65 B | -11.47 | 108 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.32 | $243.38 M | -1.59 | 133 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 LYEL
|
Lyell Immunopharma, Inc. | $1.10 | $619.50 M | -2.7 | 224 | $130,000 |
 MLTX
|
MoonLake Immunotherapeutics | $49.34 | $2.62 B | -57.88 | 50 | $0 |
 MOLN
|
Molecular Partners AG | $5.46 | $135.05 M | -2.03 | 167 | $7.04 M |
 NLTX
|
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $56.46 | $6.66 B | -10.51 | 490 | $11.58 M |
 SPRO
|
Spero Therapeutics, Inc. | $1.16 | $75.85 M | 3.19 | 46 | $96.74 M |
 TERN
|
Terns Pharmaceuticals, Inc. | $5.91 | $462.44 M | -5.67 | 66 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |